GTR Home > Tests > Search results - Limb-girdle muscular dystrophy-dystroglycanopathy, type C5

Apply filters

Showing test for 1 condition

reset

Compare labs

Your search term can be found in tests with a total of 1418 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for C1846672[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 49 tests for 1 condition in 20 labs

CMyoGene Panel (43 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (95)
Total targets (43)

CMuscular Dystrophy (LGMD/EDMD) Panel (25 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (64)
Total targets (25)

CCongenital Muscular Dystrophy Sequencing Panel

Lab: Genetic Services Laboratory University of Chicago Chicago, Illinois, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (37)
Total targets (21)

CLimb-Girdle Muscular Dystrophy NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (22)
Total targets (24)

CAutosomal Recessive Limb-Girdle Muscular Dystrophy NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (16)
Total targets (18)

CComprehensive Epilepsy Panel

Lab: Transgenomic New Haven, Connecticut, United States
Total conditions (527)
Total targets (377)

CCongenital Muscular Dystrophy NextGen Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (28)
Total targets (25)

CepiSEEK® Comprehensive Sequence Analysis for Epilepsy and Seizure Disorders (489 genes)

Lab: Courtagen Diagnostics Laboratory Courtagen Life Sciences Woburn, Massachusetts, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (641)
Total targets (439)

CLimb-Girdle Muscular Dystrophies Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (28)
Total targets (26)

CMuscular dystrophy-dystroglycanopathy type C5

Lab: Institute of Human Genetics Cologne University Cologne, Nordrhein-Westfalen, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region

CCardiomyopathy and Arrhythmia Panel, Sequencing (85 Genes) and Deletion/Duplication (83 Genes)

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (153)
Total targets (85)

CCardiomyopathy and Arrhythmia Panel, Sequencing, 85 Genes

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (153)
Total targets (85)

CLimb girdle muscular dystrophy 2I

Lab: MVZ Dortmund Dr. Eberhard and Partner Dortmund, Nordrhein-Westfalen, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region

CLimb girdle muscular dystrophy 2I

Lab: MVZ Dortmund Dr. Eberhard and Partner Dortmund, Nordrhein-Westfalen, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region

Showing 1 to 20 of 49 tests for 1 condition in 20 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.